Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Future of High-Tech Healthcare

Over the past two years, the healthcare industry has experienced significant changes in how, when, and where it utilizes technology. In addition, the way patients perceive and want to interact with the healthcare system has undergone a dramatic shift. In this “Health and Life Sciences at the Edge” podcast, host Michelle Mooney talks with Alex…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Over the past two years, the healthcare industry has experienced significant changes in how, when, and where it utilizes technology. In addition, the way patients perceive and want to interact with the healthcare system has undergone a dramatic shift. In this “Health and Life Sciences at the Edge” podcast, host Michelle Mooney talks with Alex Flores, head of Intel’s Global Health Solutions vertical, about the causes and trends driving these changes.  

“I believe three things are behind the changes we’re seeing,” says Flores. “The healthcare industry is moving at pandemic-speed; there’s been an accelerated investment in and adoption of artificial intelligence (AI); and patient expectations have evolved.” 

The pandemic forced healthcare leaders to quickly digitize many aspects of the system so care could be delivered outside the traditional four walls of clinics and hospitals. This increased the adoption AI, with more than 84% of healthcare leaders surveyed saying they expect widespread AI adoption within five years. 

Patients have come to expect healthcare to be more personal, convenient, and flexible. “The resulting ‘hybrid care models’ have created a demand for additional compute, security, data storage, and analysis, particularly in hospitals” says Flores.  

Tech and data-driven hospitals (Smart Hospitals) are employing extensible tech frameworks that enable workflow agility across healthcare partners, providers, and systems. “In today’s digital-first world,” says Flores, “Smart Hospitals are significantly increasing connectivity, intelligence and automation. Ultimately, these lead to improved care models and workflow efficiencies.” 

Intel’s superpowers – AI, ubiquitous computing, pervasive connectivity, edge to cloud infrastructure – are particularly relevant to healthcare due to the sheer amount of data generated by the healthcare system. “It’s estimated that healthcare produced about 30% of the world’s data produced worldwide,” says Flores, “but only 5% of that data gets analyzed.” This points to the need to enable more analytics at the “intelligent edge” in hospitals and clinics.  

Looking to the future, Flores is excited about how digital technologies can revolutionize the healthcare industry. In particular, he points to the concept of the “digital twin,” which allows a comprehensive and predictive model of a patient. to be generated by aggregating and coupling data with real-time information. “The digital-twin can also be applied to physical hospitals and allows stakeholders to review how implementing innovative solutions would impact operational efficiencies.”  

“The bottom line,” says Flores, “is that in order for the healthcare industry to truly transform, it will need to embrace technology and dedicate itself to improving the patient journey.” 

Connect with Alex Flores on LinkedIn 

To learn more about Smart Hospitals, visit Smart Hospital 

Follow @IntelHealth on Twitter  

Subscribe to this channel on Apple Podcasts, Spotify, and Google Podcasts to hear more from the Intel Internet of Things Group.

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512